MedPath
HSA Approval

MYCOPHENOLATE MOFETIL CAPSULES 250MG

SIN14674P

MYCOPHENOLATE MOFETIL CAPSULES 250MG

MYCOPHENOLATE MOFETIL CAPSULES 250MG

November 20, 2014

STRIDES PHARMA GLOBAL PTE. LIMITED

STRIDES PHARMA GLOBAL PTE. LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSTRIDES PHARMA GLOBAL PTE. LIMITED
Licence HolderSTRIDES PHARMA GLOBAL PTE. LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L04AA06

mycophenolic acid

Manufacturer Information

STRIDES PHARMA GLOBAL PTE. LIMITED

Strides Pharma Science Limited

Active Ingredients

Mycophenolate mofetil

250mg

FN-1501

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MYCOPHENOLATE MOFETIL CAPSULES 250MG - HSA Approval | MedPath